RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Inovio Pharmaceuticals Stock

Inovio Pharmaceuticals EBIT 2024

Inovio Pharmaceuticals EBIT

-122.25 M USD

Ticker

INO

ISIN

US45773H2013

WKN

A115GK

In 2024, Inovio Pharmaceuticals's EBIT was -122.25 M USD, a -8.38% increase from the -133.43 M USD EBIT recorded in the previous year.

The Inovio Pharmaceuticals EBIT history

YEAREBIT (undefined USD)
2029e-
2028e129.66
2027e13.76
2026e-116.69
2025e-126.24
2024e-122.25
2023-133.43
2022-267.57
2021-301.22
2020-124.08
2019-111.11
2018-94.09
2017-84.64
2016-77.24
2015-35.28
2014-39.5
2013-20.87
2012-24.65
2011-22.23
2010-19.22
2009-13.96
2008-13.66
2007-15.9
2006-13.35
2005-12.18
2004-11.51

Inovio Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Inovio Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Inovio Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Inovio Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Inovio Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Inovio Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Inovio Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Inovio Pharmaceuticals’s growth potential.

Inovio Pharmaceuticals Revenue, EBIT and net profit per share

DateInovio Pharmaceuticals RevenueInovio Pharmaceuticals EBITInovio Pharmaceuticals Net Income
2029e221.13 M undefined0 undefined35.92 M undefined
2028e324.4 M undefined129.66 M undefined104.55 M undefined
2027e177.02 M undefined13.76 M undefined24.12 M undefined
2026e16.75 M undefined-116.69 M undefined-71.58 M undefined
2025e202,000 undefined-126.24 M undefined-97.18 M undefined
2024e329,431.68 undefined-122.25 M undefined-121.99 M undefined
2023832,000 undefined-133.43 M undefined-135.12 M undefined
202210.26 M undefined-267.57 M undefined-279.82 M undefined
20211.78 M undefined-301.22 M undefined-303.66 M undefined
20207.41 M undefined-124.08 M undefined-166.41 M undefined
20194.11 M undefined-111.11 M undefined-119.36 M undefined
201830.48 M undefined-94.09 M undefined-96.97 M undefined
201742.22 M undefined-84.64 M undefined-88.21 M undefined
201635.37 M undefined-77.24 M undefined-73.74 M undefined
201540.57 M undefined-35.28 M undefined-29.19 M undefined
201410.46 M undefined-39.5 M undefined-36.12 M undefined
201313.47 M undefined-20.87 M undefined-66.03 M undefined
20124.12 M undefined-24.65 M undefined-19.67 M undefined
20119.8 M undefined-22.23 M undefined-15.25 M undefined
20106.15 M undefined-19.22 M undefined-17.61 M undefined
20099.12 M undefined-13.96 M undefined-24.41 M undefined
20082.1 M undefined-13.66 M undefined-12.97 M undefined
20074.81 M undefined-15.9 M undefined-11.23 M undefined
20063.47 M undefined-13.35 M undefined-14.35 M undefined
20055.47 M undefined-12.18 M undefined-26.36 M undefined
20041.17 M undefined-11.51 M undefined-11.71 M undefined

Inovio Pharmaceuticals stock margins

The Inovio Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Inovio Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Inovio Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Inovio Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Inovio Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Inovio Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Inovio Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Inovio Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Inovio Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Inovio Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Inovio Pharmaceuticals Margin History

Inovio Pharmaceuticals Gross marginInovio Pharmaceuticals Profit marginInovio Pharmaceuticals EBIT marginInovio Pharmaceuticals Profit margin
2029e0 %0 %16.24 %
2028e0 %39.97 %32.23 %
2027e0 %7.77 %13.63 %
2026e0 %-696.83 %-427.44 %
2025e0 %-62,494.25 %-48,110.37 %
2024e0 %-37,108.11 %-37,030.79 %
20230 %-16,036.9 %-16,240.02 %
20220 %-2,607.43 %-2,726.74 %
20210 %-16,970.03 %-17,107.55 %
20200 %-1,674.3 %-2,245.46 %
20190 %-2,702.07 %-2,902.7 %
20180 %-308.68 %-318.12 %
20170 %-200.48 %-208.92 %
20160 %-218.38 %-208.49 %
20150 %-86.97 %-71.94 %
20140 %-377.7 %-345.43 %
20130 %-154.98 %-490.29 %
20120 %-598.32 %-477.52 %
20110 %-226.91 %-155.72 %
20100 %-312.77 %-286.64 %
20090 %-153.05 %-267.66 %
20080 %-651.36 %-618.31 %
20070 %-330.75 %-233.58 %
20060 %-384.86 %-413.78 %
20050 %-222.7 %-482.22 %
20040 %-986.38 %-1,003 %

Inovio Pharmaceuticals Aktienanalyse

What does Inovio Pharmaceuticals do?

Inovio Pharmaceuticals Inc. is a US biotechnology and pharmaceutical company specializing in the development of DNA vaccines and immunotherapies. It was founded in 1979 by Dr. Joseph Kim and is headquartered in Plymouth Meeting, Pennsylvania. Inovio began working on DNA-based vaccines in the late 1990s and developed the Electroporation technology, which facilitates the introduction of DNA molecules into cells. The company has expanded its capabilities over the years and is able to generate immune responses against a variety of viruses and bacteria. They have also made advancements in using their technology to combat cancer. Inovio's business model is based on licensing technologies and collaborating with partners such as pharmaceutical companies, government agencies, and academic institutions. They also offer services for the development and production of DNA-based vaccines for academic and industrial customers. Inovio is divided into different divisions, including DNA vaccines for infectious diseases and oncology, platform technology, and cancer immunotherapy. They offer a wide range of DNA vaccines for infectious diseases such as HPV, HIV, hepatitis B and C, as well as Lassa fever and Ebola. Inovio has also made significant progress in the development of DNA-based immunotherapies for cancer, using Electroporation technology to train and activate T-cells against cancer cells. In terms of products, Inovio has various products in different stages of clinical development, but they have not yet received FDA approval for any of their products. However, they have successfully conducted clinical trials for vaccines such as HPV, which has shown 90% efficacy against the virus. In conclusion, Inovio is a specialized company in the development of DNA-based vaccines and immunotherapy for cancer. Their Electroporation technology has led to significant breakthroughs, and they continue to pursue partnerships and further development. With their focus on research and development and advancing their technologies, it seems that Inovio is on a path of continued success. Inovio Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Inovio Pharmaceuticals's EBIT

Inovio Pharmaceuticals's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Inovio Pharmaceuticals's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Inovio Pharmaceuticals's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Inovio Pharmaceuticals’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Inovio Pharmaceuticals stock

How much did Inovio Pharmaceuticals achieve in EBIT for the current year?

In the current year, Inovio Pharmaceuticals has achieved an EBIT of -122.25 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Inovio Pharmaceuticals.

How has the EBIT of Inovio Pharmaceuticals developed in recent years?

The EBIT of Inovio Pharmaceuticals has increased by -8.38% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Inovio Pharmaceuticals?

The EBIT of Inovio Pharmaceuticals is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Inovio Pharmaceuticals pay?

Over the past 12 months, Inovio Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inovio Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Inovio Pharmaceuticals?

The current dividend yield of Inovio Pharmaceuticals is .

When does Inovio Pharmaceuticals pay dividends?

Inovio Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Inovio Pharmaceuticals?

Inovio Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Inovio Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Inovio Pharmaceuticals located?

Inovio Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Inovio Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Inovio Pharmaceuticals from 11/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did Inovio Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of Inovio Pharmaceuticals in the year 2023?

In the year 2023, Inovio Pharmaceuticals distributed 0 USD as dividends.

In which currency does Inovio Pharmaceuticals pay out the dividend?

The dividends of Inovio Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Inovio Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Inovio Pharmaceuticals

Our stock analysis for Inovio Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inovio Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.